• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经病理性疼痛的流行率:社区人群中临床评估与筛查工具的比较。

The prevalence of neuropathic pain: clinical evaluation compared with screening tools in a community population.

机构信息

Olmsted Medical Center, Department of Research, Rochester, MN 55904, USA.

出版信息

Pain Med. 2009 Apr;10(3):586-93. doi: 10.1111/j.1526-4637.2009.00588.x. Epub 2009 Mar 17.

DOI:10.1111/j.1526-4637.2009.00588.x
PMID:20849570
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2964880/
Abstract

BACKGROUND

Neuropathic pain is reported to be common based on studies from specialty centers and survey studies. However, few prevalence estimates have been completed in a community population using clinical evaluation.

OBJECTIVE

To develop an estimate of the prevalence of neuropathic pain in community-dwelling adults.

METHODS

Data from a mailed survey (N = 3,575 community respondents), telephone interview (N = 907), and a clinical examination (N = 205) were linked to estimate the population prevalence of neuropathic pain. Using the clinical examination as the "gold" standard, estimates from several screening tools were developed and adjusted to the Olmsted County, MN adult population.

RESULTS

The estimated community prevalence of neuropathic pain from the clinical examination (gold standard) was 9.8%. Most other estimates were lower, including a 3.0% population prevalence using the Berger criteria and 8.8% using the Leeds Assessment of Neuropathic Symptoms and Signs. Only the prevalence rate based on self-report of nerve pain was higher (12.4%). Overlap among the groups each tool identified as having "neuropathic predominant pain" was only modest and the groups had significantly different rates of depressive symptoms, anxiety, limited functional ability, and use of complementary and alternative medicine.

CONCLUSIONS

The estimated rates and personal characteristics of community residents with "neuropathic pain" vary widely depending on the tools used to identify neuropathic pain. None of the screening tools compared well with clinical evaluation. The differences in the groups identified by alternative screening methods become of major importance when reporting neuropathic pain epidemiology, studying therapies for neuropathic pain, or attempting to translate neuropathic pain research into clinical practice.

摘要

背景

根据来自专业中心和调查研究的报告,神经病理性疼痛较为常见。然而,使用临床评估在社区人群中完成的患病率估计很少。

目的

评估社区居住成年人的神经病理性疼痛患病率。

方法

对邮寄调查(n=3575 名社区应答者)、电话访谈(n=907)和临床检查(n=205)的数据进行了链接,以估计神经病理性疼痛的人群患病率。使用临床检查作为“金标准”,开发了几种筛选工具的估计值,并对明尼苏达州奥姆斯特德县的成年人群进行了调整。

结果

临床检查(金标准)估计的社区神经病理性疼痛患病率为 9.8%。其他大多数估计值较低,包括使用 Berger 标准的人群患病率为 3.0%,使用 Leeds 评估神经病理性症状和体征的患病率为 8.8%。只有基于神经痛自我报告的患病率较高(12.4%)。每个工具确定为具有“神经病理性为主的疼痛”的组之间的重叠仅为中等,这些组具有明显不同的抑郁症状、焦虑、有限的功能能力和使用补充和替代医学的发生率。

结论

根据用于识别神经病理性疼痛的工具,社区居民中“神经病理性疼痛”的估计率和个人特征差异很大。没有一种筛选工具与临床评估相比表现良好。当报告神经病理性疼痛流行病学、研究神经病理性疼痛的疗法或试图将神经病理性疼痛研究转化为临床实践时,替代筛选方法确定的组之间的差异变得非常重要。

相似文献

1
The prevalence of neuropathic pain: clinical evaluation compared with screening tools in a community population.神经病理性疼痛的流行率:社区人群中临床评估与筛查工具的比较。
Pain Med. 2009 Apr;10(3):586-93. doi: 10.1111/j.1526-4637.2009.00588.x. Epub 2009 Mar 17.
2
Validation of the S-LANSS in the community setting.社区环境中S-LANSS的验证。
Pain. 2007 Nov;132(1-2):189-94. doi: 10.1016/j.pain.2007.07.030. Epub 2007 Sep 14.
3
Neuropathic pain in the community: more under-treated than refractory?社区中的神经性疼痛:治疗不足而非难治?
Pain. 2013 May;154(5):690-699. doi: 10.1016/j.pain.2012.12.022. Epub 2013 Jan 23.
4
An Epidemiological Study of Neuropathic Pain Symptoms in Canadian Adults.加拿大成年人神经性疼痛症状的流行病学研究。
Pain Res Manag. 2016;2016:9815750. doi: 10.1155/2016/9815750. Epub 2016 Mar 30.
5
Agreement and correlation between the self-report leeds assessment of neuropathic symptoms and signs and Douleur Neuropathique 4 Questions neuropathic pain screening tools in subjects with low back-related leg pain.下背部相关腿痛患者中,神经病理性症状和体征的自我报告利兹评估与神经病理性疼痛4问题筛查工具之间的一致性和相关性。
J Manipulative Physiol Ther. 2012 Mar-Apr;35(3):196-202. doi: 10.1016/j.jmpt.2012.02.001. Epub 2012 Mar 6.
6
Sensitivity and Specificity of a Neuropathic Screening Tool (Self-Report Leeds Assessment of Neuropathic Symptoms and Signs, S-LANSS) in Adolescents With Moderate-Severe Chronic Pain.一种神经性筛查工具(自报告利兹神经性症状和体征评估,S-LANSS)在中重度慢性疼痛青少年中的敏感性和特异性。
J Pain. 2024 Feb;25(2):451-465. doi: 10.1016/j.jpain.2023.09.006. Epub 2023 Sep 21.
7
The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research.用于识别主要为神经病理性疼痛的S-LANSS评分:在临床和邮寄研究中的应用验证
J Pain. 2005 Mar;6(3):149-58. doi: 10.1016/j.jpain.2004.11.007.
8
Prevalence of chronic pain with neuropathic characteristics in the general population.普通人群中具有神经病理性特征的慢性疼痛患病率。
Pain. 2008 Jun;136(3):380-387. doi: 10.1016/j.pain.2007.08.013. Epub 2007 Sep 20.
9
Neuropathic Pain in Low Back-Related Leg Pain Patients: What Is the Evidence of Prevalence, Characteristics, and Prognosis in Primary Care? A Systematic Review of the Literature.原发性医疗保健中与下背部相关的腿部疼痛患者的神经病理性疼痛:患病率、特征和预后的证据是什么?文献系统综述。
J Pain. 2017 Nov;18(11):1295-1312. doi: 10.1016/j.jpain.2017.04.012. Epub 2017 Jun 12.
10
Prevalence of neuropathic pain among patients with chronic low-back pain in the Arabian Gulf Region assessed using the leeds assessment of neuropathic symptoms and signs pain scale.使用利兹神经病理性症状和体征疼痛量表评估阿拉伯海湾地区慢性下腰痛患者中神经病理性疼痛的患病率。
J Int Med Res. 2010;38(6):2135-45. doi: 10.1177/147323001003800629.

引用本文的文献

1
EEG neurofeedback for the treatment of neuropathic pain in the elderly-a mechanistic review.脑电图神经反馈治疗老年人神经性疼痛——一项机制综述
Geroscience. 2025 Aug 30. doi: 10.1007/s11357-025-01848-7.
2
The prevalence of neuropathic pain pathophysiology associated with ankle fracture: A study protocol.与踝关节骨折相关的神经性疼痛病理生理学的患病率:一项研究方案。
PLoS One. 2025 Aug 19;20(8):e0327605. doi: 10.1371/journal.pone.0327605. eCollection 2025.
3
Low-intensity focused ultrasound of the spine in the treatment of chronic pain and movement disorder: a scoping review.脊柱低强度聚焦超声治疗慢性疼痛和运动障碍:一项范围综述
Front Pain Res (Lausanne). 2025 Jun 17;6:1606672. doi: 10.3389/fpain.2025.1606672. eCollection 2025.
4
Sex-chromosome complement and Activin-A shape the therapeutic potential of TNFR2 activation in a model of MS and CNP.性染色体组成和激活素A塑造了TNFR2激活在多发性硬化症和慢性神经病理性疼痛模型中的治疗潜力。
Proc Natl Acad Sci U S A. 2025 May 20;122(20):e2426771122. doi: 10.1073/pnas.2426771122. Epub 2025 May 16.
5
Discovery of Antinociceptive α9α10 Nicotinic Acetylcholine Receptor Antagonists by Stable Receptor Expression.稳定表达受体发现抗伤害性 α9α10 烟碱型乙酰胆碱受体拮抗剂。
ACS Chem Biol. 2024 Nov 15;19(11):2291-2303. doi: 10.1021/acschembio.4c00330. Epub 2024 Oct 13.
6
Using biothesiometer, Neuropathy Symptom Score, and Neuropathy Disability Score for the early detection of peripheral neuropathy: A cross-sectional study.使用生物感觉阈值测量仪、神经病变症状评分和神经病变残疾评分进行周围神经病变的早期检测:一项横断面研究。
Qatar Med J. 2024 Jul 29;2024(3):24. doi: 10.5339/qmj.2024.24. eCollection 2024.
7
Schwann Cell-Derived Exosomal Vesicles: A Promising Therapy for the Injured Spinal Cord.许旺细胞衍生的外泌体囊泡:一种有前途的脊髓损伤治疗方法。
Int J Mol Sci. 2023 Dec 10;24(24):17317. doi: 10.3390/ijms242417317.
8
The Role of microRNAs in Regulating Cancer Cell Response to Oxaliplatin-Containing Regimens.microRNAs 在调节癌细胞对含奥沙利铂方案的反应中的作用。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231206003. doi: 10.1177/15330338231206003.
9
Multimodal non-invasive non-pharmacological therapies for chronic pain: mechanisms and progress.多模态非侵入性非药物疗法治疗慢性疼痛:机制与进展。
BMC Med. 2023 Sep 29;21(1):372. doi: 10.1186/s12916-023-03076-2.
10
Pain and aging: A unique challenge in neuroinflammation and behavior.疼痛与衰老:神经炎症与行为的独特挑战。
Mol Pain. 2023 Jan-Dec;19:17448069231203090. doi: 10.1177/17448069231203090.

本文引用的文献

1
A population in pain: report from the Olmsted County health study.处于疼痛中的人群:来自奥姆斯特德县健康研究的报告。
Pain Med. 2008 Mar;9(2):166-74. doi: 10.1111/j.1526-4637.2007.00280.x.
2
Validation of the S-LANSS in the community setting.社区环境中S-LANSS的验证。
Pain. 2007 Nov;132(1-2):189-94. doi: 10.1016/j.pain.2007.07.030. Epub 2007 Sep 14.
3
Development and testing of a neuropathic pain screening questionnaire: ID Pain.一种神经性疼痛筛查问卷的开发与测试:ID疼痛问卷
Curr Med Res Opin. 2006 Aug;22(8):1555-65. doi: 10.1185/030079906X115702.
4
Medications for neuropathic pain: current trends.用于神经性疼痛的药物:当前趋势
Neurol Sci. 2006 May;27 Suppl 2:S183-9. doi: 10.1007/s10072-006-0598-7.
5
The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey.以神经性疼痛为主的慢性疼痛的流行病学。一项普通人群调查的结果。
J Pain. 2006 Apr;7(4):281-9. doi: 10.1016/j.jpain.2005.11.008.
6
Diabetic peripheral neuropathic pain: clinical and quality-of-life issues.糖尿病性周围神经病理性疼痛:临床及生活质量问题
Mayo Clin Proc. 2006 Apr;81(4 Suppl):S3-11. doi: 10.1016/s0025-6196(11)61474-2.
7
A questionnaire study investigating the prevalence of the neuropathic component of chronic pain after thoracic surgery.一项调查胸外科手术后慢性疼痛的神经病理性成分患病率的问卷调查研究。
Eur J Cardiothorac Surg. 2006 May;29(5):800-5. doi: 10.1016/j.ejcts.2006.02.002. Epub 2006 Apr 3.
8
Screening of neuropathic pain components in patients with chronic back pain associated with nerve root compression: a prospective observational pilot study (MIPORT).神经根受压相关慢性背痛患者神经病理性疼痛成分的筛查:一项前瞻性观察性试点研究(MIPORT)
Curr Med Res Opin. 2006 Mar;22(3):529-37. doi: 10.1185/030079906X89874.
9
Silent pain sufferers.默默承受痛苦的人。
Mayo Clin Proc. 2006 Feb;81(2):167-71. doi: 10.4065/81.2.167.
10
[Epidemiological study of prevalence, incidence and neuropathic pain characterization in neurology units. PREVADOL study].[神经病学科中患病率、发病率及神经性疼痛特征的流行病学研究。PREVADOL研究]
Neurologia. 2005 Oct;20(8):385-9.